ENTRY       D00426                      Drug
NAME        Risperidone (JP18/USP/INN);
            Risperdal (TN)
PRODUCT     PERSERIS (Indivior)
            RISPERDAL (REMEDYREPACK)
            RISPERDAL CONSTA (Janssen Pharmaceuticals)
            RISPERIDONE (Aphena Pharma Solutions - Tennessee)
            RISPERIDONE (Aphena Pharma Solutions - Tennessee)
            RISPERIDONE (Aphena Pharma Solutions - Tennessee)
            RISPERIDONE (Aphena Pharma Solutions - Tennessee)
            RISPERIDONE (Janssen Pharmaceutical)
            RISPERIDONE (Janssen Pharmaceuticals)
            RISPERIDONE (REMEDYREPACK)
            RYKINDO (Shandong Luye Pharmaceutical)
            UZEDY (Teva Pharmaceuticals USA)
  GENERIC   RISPERIDONE (A-S Medication Solutions)
            RISPERIDONE (A-S Medication Solutions)
            RISPERIDONE (Ajanta Pharma USA)
            RISPERIDONE (American Health Packaging)
            RISPERIDONE (Amneal Pharmaceuticals LLC)
            RISPERIDONE (Amneal Pharmaceuticals NY LLC)
            RISPERIDONE (Aphena Pharma Solutions - Tennessee)
            RISPERIDONE (Aphena Pharma Solutions - Tennessee)
            RISPERIDONE (Aphena Pharma Solutions - Tennessee)
            RISPERIDONE (Aurobindo Pharma Limited)
            RISPERIDONE (AvKARE)
            RISPERIDONE (AvKARE)
            RISPERIDONE (Bryant Ranch Prepack)
            RISPERIDONE (Bryant Ranch Prepack)
            RISPERIDONE (Bryant Ranch Prepack)
            RISPERIDONE (Bryant Ranch Prepack)
            RISPERIDONE (Bryant Ranch Prepack)
            RISPERIDONE (Bryant Ranch Prepack)
            RISPERIDONE (Bryant Ranch Prepack)
            RISPERIDONE (Cardinal Health 107)
            RISPERIDONE (Chartwell RX)
            RISPERIDONE (Clinical Solutions Wholesale)
            RISPERIDONE (Hikma Pharmaceuticals USA)
            RISPERIDONE (Jubilant Cadista Pharmaceuticals)
            RISPERIDONE (Lannett Company)
            RISPERIDONE (Major Pharmaceuticals)
            RISPERIDONE (NCS HealthCare of KY)
            RISPERIDONE (NuCare Pharmaceuticals)
            RISPERIDONE (PD-Rx Pharmaceuticals)
            RISPERIDONE (PD-Rx Pharmaceuticals)
            RISPERIDONE (Par Pharmaceutical)
            RISPERIDONE (Proficient Rx LP)
            RISPERIDONE (Proficient Rx LP)
            RISPERIDONE (Proficient Rx LP)
            RISPERIDONE (Proficient Rx LP)
            RISPERIDONE (Proficient Rx LP)
            RISPERIDONE (Quality Care Products)
            RISPERIDONE (REMEDYREPACK)
            RISPERIDONE (REMEDYREPACK)
            RISPERIDONE (REMEDYREPACK)
            RISPERIDONE (REMEDYREPACK)
            RISPERIDONE (REMEDYREPACK)
            RISPERIDONE (REMEDYREPACK)
            RISPERIDONE (REMEDYREPACK)
            RISPERIDONE (REMEDYREPACK)
            RISPERIDONE (REMEDYREPACK)
            RISPERIDONE (REMEDYREPACK)
            RISPERIDONE (REMEDYREPACK)
            RISPERIDONE (REMEDYREPACK)
            RISPERIDONE (REMEDYREPACK)
            RISPERIDONE (REMEDYREPACK)
            RISPERIDONE (RPK Pharmaceuticals)
            RISPERIDONE (Solco Healthcare US)
            RISPERIDONE (Sun Pharmaceutical Industries)
            RISPERIDONE (Torrent Pharmaceuticals Limited)
            RISPERIDONE (Tris Pharma)
            RISPERIDONE (Zydus Lifesciences Limited)
            RISPERIDONE (Zydus Lifesciences Limited)
            RISPERIDONE (Zydus Pharmaceuticals USA)
            RISPERIDONE (Zydus Pharmaceuticals USA)
FORMULA     C23H27FN4O2
EXACT_MASS  410.2118
MOL_WEIGHT  410.4845
CLASS       Neuropsychiatric agent
             DG01478  Dopamine antagonist
              DG01474  Dopamine D2-receptor antagonist
             DG03005  Serotonin-dopamine antagonist (SDA)
             DG03200  Antipsychotic agent
              DG03064  Atypical antipsychotic
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 1179
            ATC code: N05AX08
            Product: D00426<JP/US>
EFFICACY    Antipsychotic, Neuroleptic
  DISEASE   Schizophrenia [DS:H01649]
            Bipolar mania [DS:H01653]
COMMENT     Serotonin-dopamine antagonists (SDA)
            Active form of prodrug: Paliperidone [DR:D05339]
TARGET      DRD2 [HSA:1813] [KO:K04145]
            HTR2A [HSA:3356] [KO:K04157]
  PATHWAY   hsa04080(1813+3356)  Neuroactive ligand-receptor interaction
            hsa04726(3356)  Serotonergic synapse
            hsa04728(1813)  Dopaminergic synapse
METABOLISM  Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07028  Antipsychotics
            map07211  Serotonin receptor agonists/antagonists
            map07213  Dopamine receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05A ANTIPSYCHOTICS
                N05AX Other antipsychotics
                 N05AX08 Risperidone
                  D00426  Risperidone (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antipsychotics
              2nd Generation/Atypical
               Risperidone
                D00426  Risperidone (JP18/USP/INN)
             Bipolar Agents
              Bipolar Agents, Other
               Risperidone
                D00426  Risperidone (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               117  Psychotropics
                1179  Others
                 D00426  Risperidone (JP18/USP/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                D00426  Risperidone
              DG03005  Serotonin-dopamine antagonist (SDA)
               D00426  Risperidone
              DG03200  Antipsychotic agent
               DG03064  Atypical antipsychotic
                D00426  Risperidone
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               D00426  Risperidone
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D00426  Risperidone
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Dopamine
                DRD2
                 D00426  Risperidone (JP18/USP/INN) &lt;JP/US&gt;
               Serotonin
                HTR2A
                 D00426  Risperidone (JP18/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00426  Risperidone
              D00426  Risperidone tablets
              D00426  Risperidone fine granules
              D00426  Risperidone solution
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00426
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D00426
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00426
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D00426
            Prodrugs [br08324.html]
             D00426
DBLINKS     CAS: 106266-06-2
            PubChem: 7847492
            ChEBI: 8871
            PDB-CCD: 8NU
            LigandBox: D00426
            NIKKAJI: J138.382E
ATOM        30
            1   C1y C    22.2076  -18.2560
            2   C1x C    22.2076  -16.8437
            3   C1x C    23.4315  -18.9622
            4   C1x C    23.4315  -16.1376
            5   C1x C    24.6555  -18.2560
            6   N1y N    24.6555  -16.8437
            7   C1b C    25.8795  -16.1847
            8   C1b C    27.0564  -16.8437
            9   C8y C    28.2333  -16.1847
            10  C8y C    29.4572  -16.8437
            11  C8y C    28.2333  -14.7724
            12  N4y N    30.6813  -16.1847
            13  O5x O    29.4572  -18.2560
            14  N5x N    29.4572  -14.0663
            15  C1a C    27.0564  -14.0663
            16  C8y C    30.6813  -14.7253
            17  C1x C    31.9523  -16.8437
            18  C1x C    31.9523  -14.0663
            19  C1x C    33.1292  -16.1847
            20  C1x C    33.1292  -14.7724
            21  C8y C    20.9846  -18.9624
            22  N5x N    19.8537  -18.1619
            23  O2x O    18.7431  -18.9900
            24  C8y C    19.1873  -20.3023
            25  C8y C    20.5727  -20.2852
            26  C8x C    18.4886  -21.5043
            27  C8y C    19.1911  -22.7295
            28  C8x C    20.6034  -22.7337
            29  C8x C    21.3021  -21.5317
            30  X   F    18.4827  -23.9479
BOND        34
            1     1   2 1
            2     1   3 1
            3     2   4 1
            4     3   5 1
            5     4   6 1
            6     6   7 1
            7     7   8 1
            8     8   9 1
            9     9  10 1
            10    9  11 2
            11   10  12 1
            12   10  13 2
            13   11  14 1
            14   11  15 1
            15   12  16 1
            16   12  17 1
            17   16  18 1
            18   17  19 1
            19   18  20 1
            20    5   6 1
            21   14  16 2
            22   19  20 1
            23    1  21 1
            24   21  22 2
            25   22  23 1
            26   23  24 1
            27   24  25 2
            28   21  25 1
            29   24  26 1
            30   26  27 2
            31   27  28 1
            32   28  29 2
            33   29  25 1
            34   27  30 1
///
